Table 2 Baseline characteristics of the participants
From: Pregnancy outcomes in women with pulmonary hypertension: a retrospective study in China
Covariates | Total (n = 154) | PH groups | P-value | |||
|---|---|---|---|---|---|---|
iPAH (n = 6) | CHD-PAH (n = 41) | oPAH (n = 45) | LHD-PH (n = 62) | |||
Age, mean ± SD | 30.9 ± 5.1 | 28.7 ± 4.5 | 30.6 ± 4.8 | 30.9 ± 4.6 | 31.5 ± 5.7 | 0.539 |
Gestational week, Median (IQR) | 35.5 (31.0, 38.0) | 34.5 (30.2, 36.5) | 36.0 (30.0, 38.0) | 36.0 (29.0, 39.0) | 35.0 (32.0, 38.0) | 0.958 |
Primipara, n (%) | 99 (64.3) | 2 (33.3) | 24 (58.5) | 28 (62.2) | 45 (72.6) | 0.175 |
Multiparous, n (%) | 46 (29.9) | 4 (66.7) | 14 (34.1) | 13 (28.9) | 15 (24.2) | 0.173 |
sPAP, Median (IQR) | 47.0 (37.0, 67.2) | 107.0 (78.8, 125.5) | 59.0 (39.0, 92.0) | 40.0 (36.0, 49.0) | 50.0 (38.2, 62.8) | < 0.001 |
sPAP, n (%) | < 0.001 | |||||
36–49 mmHg | 82 (53.2) | 1 (16.7) | 16 (39) | 35 (77.8) | 30 (48.4) | |
50–69 mmHg | 34 (22.1) | 0 (0) | 7 (17.1) | 8 (17.8) | 19 (30.6) | |
≥ 70 mmHg | 38 (24.7) | 5 (83.3) | 18 (43.9) | 2 (4.4) | 13 (21) | |
Place of residence, n (%) | 0.128 | |||||
City | 79 (51.3) | 1 (16.7) | 19 (46.3) | 21 (46.7) | 38 (61.3) | |
rural | 75 (48.7) | 5 (83.3) | 22 (53.7) | 24 (53.3) | 24 (38.7) | |
Regular obstetric examinations, n (%) | 0.038 | |||||
NO | 25 (16.2) | 3 (50) | 10 (24.4) | 5 (11.1) | 7 (11.3) | |
YES | 129 (83.8) | 3 (50) | 31 (75.6) | 40 (88.9) | 55 (88.7) | |
NYHA cardiac function classification, n (%) | < 0.001 | |||||
I | 82 (53.2) | 2 (33.3) | 16 (39) | 36 (80) | 28 (45.2) | |
II | 30 (19.5) | 0 (0) | 15 (36.6) | 2 (4.4) | 13 (21) | |
III | 19 (12.3) | 1 (16.7) | 9 (22) | 0 (0) | 9 (14.5) | |
IV | 23 (14.9) | 3 (50) | 1 (2.4) | 7 (15.6) | 12 (19.4) | |
Length of stay (days), Median (IQR) | 9.0 (6.0, 13.0) | 6.5 (2.0, 14.0) | 8.0 (5.0, 11.0) | 8.0 (5.0, 15.0) | 10.0 (7.0, 12.8) | 0.279 |